U S Physical Therapy Inc: Form 10-Q/A for the period ended Jun 30, 2012
Filed with the SEC on Sep 6, 2012 and accepted by EDGAR at Sep 6, 2012, 15:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-04-01 to 2012-06-30 | $64.0m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2012-01-01 to 2012-06-30 | $126.5m | us-gaap:SalesRevenueNet |
| Gross profit | 3 months2012-04-01 to 2012-06-30 | $17.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2012-01-01 to 2012-06-30 | $33.1m | us-gaap:GrossProfit |
| Operating income | 3 months2012-04-01 to 2012-06-30 | $10.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-01-01 to 2012-06-30 | $20.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-04-01 to 2012-06-30 | $145.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2012-01-01 to 2012-06-30 | $307.0k | us-gaap:InterestExpense |
| Income tax | 3 months2012-04-01 to 2012-06-30 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-01-01 to 2012-06-30 | $6.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-04-01 to 2012-06-30 | $4.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2012-01-01 to 2012-06-30 | $9.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-04-01 to 2012-06-30 | $0.41 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-01-01 to 2012-06-30 | $0.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-04-01 to 2012-06-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-01-01 to 2012-06-30 | $0.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-04-01 to 2012-06-30 | 11,903 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-01-01 to 2012-06-30 | 11,872 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-01-01 to 2012-06-30 | $19.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2012-01-01 to 2012-06-30 | $1.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2012-01-01 to 2012-06-30 | $2.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2012-06-30 | $8.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-06-30 | $44.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-06-30 | $170.6m | us-gaap:Assets |
| Current liabilities | At period end2012-06-30 | $16.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-06-30 | $38.1m | us-gaap:Liabilities |
| Long-term debt | At period end2012-06-30 | $20.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-06-30 | $609.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-06-30 | $115.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-12-382312. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.